2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theConvalescent Plasma Therapy Market?

The global convalescent plasma therapy (CPT) market is expected to grow as a result of the increasing efficacy and safety demonstrated during clinical trials for COVID-19 patients. Convalescent plasma transfusion, historically used for other infectious diseases like SARS-1, MERS, and H1N1, has shown positive results in recent trials. For example, a June 2022 study from Houston Methodist Hospital found CPT to be safe and effective, with a 76% recovery rate. Another study published in the Journal of Medical Virology in May 2020 indicated that CPT could reduce mortality rates in critically ill patients and help increase neutralizing antibody titers. The demonstrated safety and efficacy of CPT in treating COVID-19 patients will drive the growth of the global convalescent plasma therapy market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

#What is the Anticipated CAGR of theConvalescent Plasma Therapy Market, and What Factors Will Drive It?

The convalescent plasma therapy market has shown rapid growth. It is projected to grow from $0.05 billion in 2024 to $0.06 billion in 2025, at a CAGR of 11.4%. This growth has been driven by infectious disease outbreaks, advances in immunotherapy, emergency use authorizations, and heightened awareness.

The convalescent plasma therapy market is projected to experience significant expansion over the next several years. It is forecasted to reach $0.09 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.7%. This growth will be fueled by the evolution of infectious diseases, the rise of immunotherapies, the establishment of regulatory frameworks, enhanced global readiness, and public health strategies. Notable trends include standardized methods for plasma collection, targeted component use, individualized treatments, telehealth support, and studies on long-term effects.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3233

What Are the Most Significant Market Trends Transforming theConvalescent Plasma Therapy Market?

The development of antibody-based immunotherapy as a potential treatment for COVID-19 presents opportunities for the convalescent plasma therapy market. This therapy uses antibodies from donors who have fought the virus to enhance the recipient’s immunity. Various companies are advancing trials, forming collaborations, and making investments in antibody-based COVID-19 treatments. For instance, in August 2023, Regeneron Pharmaceuticals Inc., a US-based biotech firm, partnered with the Biomedical Advanced Research and Development Authority (BARDA) to support the clinical development, manufacturing, and regulatory processes for next-generation monoclonal antibody treatments to prevent SARS-CoV-2 infections. This collaboration is part of Project NextGen, a U.S. Department of Health and Human Services (HHS) initiative to develop modern COVID-19 vaccines and therapies. In this partnership, Regeneron will independently propose an antibody candidate, which BARDA and Regeneron will jointly evaluate for further research and regulatory efforts. The focus on antibody-based treatments is expected to drive growth in the convalescent plasma therapy market.

Who Are the Dominant Market Players Pushing the Boundaries of theConvalescent Plasma Therapy Market?

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

What Are the Core Segments of the Convalescent Plasma Therapy Market, and How Do They Contribute to Growth?

The convalescent plasma therapy market covered in this report is segmented –

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp

What Regions Are Dominating the Convalescent Plasma Therapy Market Growth?

North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Convalescent Plasma Therapy Market 2025, By The Business Research Company:

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Radiotherapy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Cold Plasma Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: